Liang Dai

9PUBLICATIONS
13CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsMolecular targetsCharacterisation of biological macromoleculesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 10, 2026
Design, Synthesis, and Biological Evaluation of Arylimidazole Derivatives as Potent PPARδ Agonists for the Treatment of Renal Fibrosis.

Zhiqi Feng, Junkai Xie, Dongliang Hou

|Jan 28, 2025
Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation.

Xi Han, Guangcai Ma, Ruikun Peng

|Mar 11, 2024
Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity.

Liu Liu, Honghan Zhang, Jie Hou

|May 27, 2023
Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases.

Zhiqi Feng, Jiehao Xiang, Gang Sun

|Dec 01, 2022
Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer.

Xing Li, Shanlin Yang, Honghan Zhang

|Jun 09, 2022
Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor.

Yongjun Zang, Luyang Tai, Yuanyang Hu

Pageof 2

Frequent Collaborators

9 joint publications

Hongbin Sun

9 joint publications

Haoliang Yuan

7 joint publications

Qinglong Xu

6 joint publications

Xiaoan Wen